Immix Biopharma, Inc. 4

Immix Biopharma CFO/President Gabriel S. Morris received an option award for 500,000 shares of common stock at $8.78 per share.

On May 22, 2026, Immix Biopharma, Inc. granted CFO and President Gabriel S. Morris a stock option to purchase 500,000 shares of common stock at an exercise price of $8.78 per share, with the option vesting in 48 equal monthly installments over four years, subject to his continued service. This award represents a long‑term equity incentive rather than an open‑market transaction and, assuming full vesting and exercise, would give Morris ownership of 500,000 shares of the company’s common stock. Using the option exercise price as a proxy for value, the option grant has a notional underlying value of approximately $4.39 million, and his post‑transaction beneficial ownership corresponds to these 500,000 option-linked shares.

Filing Facts

CIK

1873835

Ticker

IMMX

Form

4

Source Type

sec

Accession

0001493152-26-026428

Alert Tier

7